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Abstract
Background: Partial trisomy of the short arm of chromosome 9 is among the most common autosomal structural
chromosomal anomalies leading to chromosomal imbalance in human. Clinical characteristics are craniofacial
dysmorphism including hypertelorism, prominent nose, deep-set eyes, and down-slanting palpebral fissures. The
degree of clinical severity in partial trisomy 9p roughly correlates with the size of the chromosomal imbalance.
Therefore, breakpoints as well as clinical findings need to be precisely defined for differential diagnosis.
Results: Chromosomes of a young female were analyzed due to primary amenorrhea, short stature, developmental
delay and a characteristic facial appearance. Cytogenetic analysis using GTG banding identified a karyotype 46, XX,
add(9pter). Surprisingly the application of high resolution molecular cytogenetic techniques characterized a partial
trisomy 9p24.2-p22 and partial monosomy 9pter-p24.2. To the best of our knowledge only four similar case were
reported by now.
Conclusion: Attempts for genotype-phenotype correlations for partial trisomy 9p might have been hampered by
the fact that more complex, cryptic aberrations were neither considered nor detected in comparable clinical cases.
Background
Trisomy 9p is the fourth most frequent chromosome
anomaly in life-born after trisomy 21, 18 and 13. A pos-
sible explanation might be that these chromosomes as
well as 9p are relatively gene poor [1-3]. The first case
of trisomy 9p was described in 1970 [1]. Since then,
more than 150 patients with partial or complete trisomy
9p have been reported and this kind of chromosomal
imbalance was characterized as a clinically recognizable
syndrome. In most patients, the trisomic segment was
transmitted from a parent carrying a reciprocal balanced
translocation and only a small number arose from de
novo duplications [3]. Rearrangements involving the dis-
tal region of the short arm of chromosome 9 (9p22 to
9p24) are well described and may involve deletions or
duplications resulting in the partial monosomy [4] or
the partial trisomy 9p syndrome [3]. Characteristic clini-
cal features of partial trisomy 9p are mental retardation
of various degree, short stature, craniofacial abnormal-
ities, short fingers, simian crease, and single crease of
the fifth finger. Additional symptoms like microcephaly,
cleft lip and palate, malformed ears, and skeletal, nail,
cardiac, and genital anomalies have also been observed
[3]. Partial monosomy 9p or deletion 9p is also reported
to be associated with a well defined phenotype charac-
terized by mental retardation, flat occiput, trigonoce-
phaly, inner epicanthal folds, mild hypertelorism,
strabismus, flat nasal bridge, long philtrum, high arched
palate, and flat feet [4].
In clinical cytogenetics, the precise identification of
the chromosomal abnormality is a key factor when con-
sidering genotype-phenotype correlation. Advances in
molecular cytogenetics have allowed more precise analy-
sis of complex chromosomal rearrangements, especially
with FISH techniques, spectral karyotyping, conventional
comparative genomic hybridization (CGH) and FISH-
banding [5]. The possibilities of array-CGH also refined
the accuracy of characterization of complex chromoso-
mal anomalies, such as unbalanced intrachromosomal
rearrangements in general [3].
Here we report a new case of partial trisomy 9p invol-
ving cryptic monosomy of 9pter and discuss the possible
impact of the detection of this case on the genotype-
phenotype correlation in trisomy 9p.
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The patient, a 20-year-old female, was the first child of
healthy non-consanguineous 26-year old mother and
33-year-old father. The girl was born at 37th weeks of
gestation with a birth weight of 3,500 g; birth length
and head circumference were not recorded. She was
referred to cytogenetic analysis at age of 20 years due to
a primary amenorrhea. Clinical examination revealed
short stature (142 cm), IQ at the lower limit of normal,
growth and developmental delay, a characteristic facial
appearance (downturned mouth, bulbous nose, short
philtrum, wide neck, low set ears, deep set eyes, thick
lips), single crease of the fifth finger, short thumb and
fifth finger (bilateral), flat feet and malformed toe-nails
(see Fig. 1). The bone age was 16 years and the external
genitalia were normal.
Figure 1 Typical phenotypical feature of the present patient: A) Facial appearance. B) Short neck and low set ears. C) Hand with short
thumb and 5th finger (present bilateral). D) Malformed nails on toes and flat feet (present bilateral)
Figure 2 GTG-banding revealed a 46, XX, add(9pter); a duplication of 9p material was suggested. The derivative chromosome is marked
by an arrowhead.
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cm) with large ovaries (46 to 47 mm) and polycystic ovar-
ies. Hair distribution on the pubic is PHIII type, breast
development is BIII type. Hormone levels: FSH 3.12 (nor-
mal up to 3.5-3.0 IU/l), LH 1.46 (normal up to 25 IU/l)
and prolactin 45.3 (normal up to 29 ng/ml). The primary
amenorrhea was treated by hormonal medication, leading
to menstruation, which continued after drug was taken.
Banding in conventional cytogenetics detected a kar-
yotype of 46, XX, add(9pter) in all cells (Fig. 2). This
finding was further studied by molecular cytogenetics;
applying aMCB [6] and the subtelomeric probe specific
for 9p (Fig. 3) the following result was obtained: 46, XX,
der(9)(:p22->p24.2::p24.2- > pter) (20). The karyotypes
o ft h em o t h e ra n dt h ef a t h e rw e r e4 6 ,X Xa n d4 6 ,X Y
respectively.
Discussion
Partial trisomy 9p was reported in numerous cases. It
was seen as a result of different types of translocations,
either de novo or inherited ones. The high frequency of
the partial trisomy 9p may indicate a particular break-
point sensitively of one or more regions of chromosome
9p [1,3,7].
Here we present the first case having both: partial tris-
omy 9p24.2-p22 and partial monosomy 9pter-p24.2.
Symptoms typical for partial trisomy 9p were in the pre-
sent patient short stature, short fingers and single crease
of the fifth finger and nail anomalies. The finding of flat
feet is more characteristic for partial monosomy of 9p.
Typically observed in both conditions are mental retar-
dation and craniofacial abnormalities. A similar case
with partial trisomy 9p24.2-p21.3 and partial monosomy
9pter-p24.2 was recently reported [3]. There, as possibly
specific features for this ‘duplication/deletion 9p’ condi-
tion, cleft palate and large eyes were discussed. How-
ever, both clinical features were absent in our patient.
Besides, three other patients with partial trisomy 9p22.2-
p13.3/partial monosomy 9pter-p22.2 [8], partial trisomy
9p22.3-p12/partial monosomy 9pter-p22.3 [8], and par-
tial trisomy 9p22-p13/partial monosomy 9pter-p22 [9]
were published. For all these cases the derivative
Figure 3 Karyotype and chromosomal aberrations were confirmed using molecular cytogenetic approaches. (A) A deletion on derivative
chromosome 9pter was identified using the subtelomeric probe 9pter; application of the probe LSI 9p21 revealed that the breakpoint in the
derivative chromosome 9 was distal from 9p21; the CEP 9 probe was used as a control. (B) The application of aMCB(9) characterized the
additional material on derivative as chromosome 9 derived material and characterized the duplication of chromosome 9 in more detail.
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break, similar as in comparable cases a neo-telomere
formation might be considered here, as well [10].
The phenotypic effects of different trisomic regions of
chromosome 9p were reviewed [3] comparing the cyto-
genetic and clinical findings of ~150 previously pub-
lished cases with partial or complete trisomy 9p. The
majority of these cases were caused by an unbalanced
translocation involving other chromosomes, as well. The
impact of these additional segments on the phenotype
was hard to be determined. Furthermore, the so-called
characteristic trisomy 9p phenotype showed the best
correlation with the 9p22 region [3]. Thus, the involve-
ment of region 9p22 to9p24 in the present patient is in
concordance with the general phenotype features of the
partial trisomy 9p syndrome with mental retardation,
developmental delay, short stature, characteristic facial
appearance.
The critical region for viable partial deletions of the
short arm of chromosome 9 seems to be relatively
small. Up to present only comparatively minor terminal
deletions of 9p, having relatively unspecific clinical
signs, are reported [4,11]. Thus, overall, more cases
characterized as having partial trisomy 9p syndrome
might be found to be more complex than initially
thought when analyzing them by FISH-banding or
array-CGH approaches.
Materials and methods
Chromosome analysis
Chromosome analysis using GTG-banding was done
according to standard procedures [12]. A total of 20
metaphases analyzed from stimulated peripheral blood
culture were analyzed. Karyotypes were described
according to the International System for Human Cyto-
genetic Nomenclature [13].
Molecular cytogenetics
Fluorescence in situ hybridization (FISH) was done
according to manufacturer’s instructions using a locus
specific probe LSI 9p21, a subtelomeric (ST) probe for
the short arm of chromosome 9 and a chromosome
enumeration probe (CEP) 9 (Abbott Molecular/Vysis,
USA). An array-proven multicolor banding probe
(aMCB) set for chromosome 9 was applied as
described [6,14]. A total of 20 metaphase spreads were
analyzed, each using a fluorescence microscope (AxioI-
mager.Z1 mot, Zeiss) equipped with appropriate filter
sets to discriminate between a maximum of five fluor-
ochromes and the counterstain DAPI (4’,6- diamino-2-
phenylindole). Image capturing and processing were
carried out using an ISIS imaging system (MetaSys-
tems, Altlussheim, Germany) for the evaluation of
aMCB.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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